Literature DB >> 11151924

Norfloxacin-induced eosinophilic necrotizing granulomatous hepatitis.

E Björnsson, R Olsson, H Remotti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11151924     DOI: 10.1111/j.1572-0241.2000.03404.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  6 in total

1.  Necrotizing granulomatous hepatitis as an unusual manifestation of Lyme disease.

Authors:  Antonela C Zanchi; Alan R Gingold; Neil D Theise; Albert D Min
Journal:  Dig Dis Sci       Date:  2007-07-20       Impact factor: 3.199

2.  Clinical and histopathologic features of fluoroquinolone-induced liver injury.

Authors:  Eric S Orman; Hari S Conjeevaram; Raj Vuppalanchi; James W Freston; James Rochon; David E Kleiner; Paul H Hayashi
Journal:  Clin Gastroenterol Hepatol       Date:  2011-02-26       Impact factor: 11.382

3.  Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database.

Authors:  D W Clark; D Layton; L V Wilton; G L Pearce; S A Shakir
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

4.  Resolution of norfloxacin-induced acute liver failure after N-acetylcysteine therapy: further support for the use of NAC in drug-induced ALF?

Authors:  Timothy Ross Elliott; Tiffany Symes; George Kannourakis; Peter Angus
Journal:  BMJ Case Rep       Date:  2016-01-06

5.  Solitary Hepatic Eosinophilic Granuloma Accompanied by Eosinophilia Without Parasitosis: Report of a Case.

Authors:  Takatsugu Yamamoto; Toru Miyazaki; Yukiko Kurashima; Kazunori Ohata; Masato Okawa; Shogo Tanaka; Takahiro Uenishi; Katsuhiko Miyaji; Nobusuke Fukumoto
Journal:  Int Surg       Date:  2015-06

Review 6.  Fluoroquinolone-induced liver injury: three new cases and a review of the literature.

Authors:  Anna Licata; Claudia Randazzo; Ilaria Morreale; Giuseppe Butera; Natale D'Alessandro; Antonio Craxì
Journal:  Eur J Clin Pharmacol       Date:  2012-01-14       Impact factor: 3.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.